A new trading day began on Monday, with Relay Therapeutics Inc (NASDAQ: RLAY) stock price down -3.91% from the previous day of trading, before settling in for the closing price of $8.18. RLAY’s price has ranged from $1.77 to $9.04 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -23.05%. Meanwhile, its annual earnings per share averaged 26.63%. With a float of $130.41 million, this company’s outstanding shares have now reached $172.63 million.
Relay Therapeutics Inc (RLAY) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Relay Therapeutics Inc is 24.76%, while institutional ownership is 74.69%. The most recent insider transaction that took place on Nov 03 ’25, was worth 434,511. In this transaction President and CEO of this company sold 62,073 shares at a rate of $7.00, taking the stock ownership to the 703,215 shares. Before that another transaction happened on Oct 29 ’25, when Company’s insider sold 21,394 for $7.50, making the entire transaction worth $160,455. This insider now owns 337,469 shares in total.
Relay Therapeutics Inc (RLAY) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.45 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.64% during the next five years compared to -23.05% drop over the previous five years of trading.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Here are Relay Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 19.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 162.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.75, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.66 in one year’s time.
Technical Analysis of Relay Therapeutics Inc (RLAY)
Looking closely at Relay Therapeutics Inc (NASDAQ: RLAY), its last 5-days average volume was 1.61 million, which is a drop from its year-to-date volume of 1.76 million. As of the previous 9 days, the stock’s Stochastic %D was 30.74%.
During the past 100 days, Relay Therapeutics Inc’s (RLAY) raw stochastic average was set at 79.41%, which indicates a significant increase from 14.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.44 in the past 14 days, which was higher than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.47, while its 200-day Moving Average is $4.62. However, in the short run, Relay Therapeutics Inc’s stock first resistance to watch stands at $8.25. Second resistance stands at $8.63. The third major resistance level sits at $8.93. If the price goes on to break the first support level at $7.57, it is likely to go to the next support level at $7.27. Now, if the price goes above the second support level, the third support stands at $6.89.
Relay Therapeutics Inc (NASDAQ: RLAY) Key Stats
With a market capitalization of 1.36 billion, the company has a total of 173,322K Shares Outstanding. Currently, annual sales are 10,010 K while annual income is -337,710 K. The company’s previous quarter sales were 680 K while its latest quarter income was -70,380 K.
